Authors
No takes yet. Share an insight, caveat, or question.
This editorial highlights that while short-term recombinant human GH replacement therapy is effective for severe adult GHD, questions remain regarding long-term use and funding.
Simpson et al. (2000) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: